Meta-analysis of amantadine efficacy for improving preclinical research reliability.

Philip Stanley, Elsa Y. Pioli, Rouba Kozak, Michael Popiolek, Erwan Bezard
Mov Disord.. 2018-10-01; 33(10): 1555-1557
DOI: 10.1002/mds.27486


Lire sur PubMed

---

1. Mov Disord. 2018 Oct;33(10):1555-1557. doi: 10.1002/mds.27486. Epub 2018 Oct 4.

Meta-analysis of amantadine efficacy for improving preclinical research
reliability.

Stanley P(1), Pioli EY(2), Kozak R(3), Popiolek M(3), Bezard E(2)(4)(5).

Author information:
(1)Research Statistics, Pfizer Worldwide Research and Development, Cambridge,
United Kingdom.
(2)Motac Neuroscience, Manchester, United Kingdom.
(3)Internal Medicine Research Unit, Pfizer Worldwide Research and Development,
Cambridge, Massachusetts, USA.
(4)Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux,
France.
(5)Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293,
Institut des Maladies Neurodégénératives, Bordeaux, France.

DOI: 10.1002/mds.27486
PMID: 30288778

Auteurs Bordeaux Neurocampus